U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Wednesday.
Shares of Macy’s, Inc. M fell sharply in today's pre-market trading after the company reported third-quarter financial results and lowered FY24 EPS outlook.
Macy's expects 2024 sales of $22.3 billion—$22.5 billion, compared to prior guidance of $22.1 billion—$22.4 billion and a consensus of $22.42 billion. Macy's expects 2024 adjusted EPS of $2.25-$2.50 compared to prior guidance of $2.34-$2.69 and a consensus of $2.73, including accounting error.
The company expects a 2024 comparable owned-plus-licensed-plus-marketplace sales change of Down ~1.0% to ~flat versus 2023 versus Down ~2.0% to down ~0.5% expected earlier.
Macy’s shares dipped 11.2% to $14.84 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- ImmunityBio, Inc. IBRX shares fell 29.4% to $3.26 in pre-market trading after the company announced the pricing of its $100 million offering of 33,333,334 shares at $3.00 per share.
- Acelyrin, Inc. SLRN shares dipped 13.8% to $3.4999 in pre-market trading after the company announced its Phase 2b/3 study of Izokibep did not meet its primary endpoint, with secondary endpoints also failing to achieve statistical significance.
- Dave & Buster’s Entertainment, Inc. PLAY shares dipped 14.1% to $31.62 in pre-market trading after the company reported worse-than-expected third-quarter EPS and sales. Multiple analysts downgraded the stock following the report.
- Bausch + Lomb Corporation BLCO shares fell 12.4% to $18.10 in pre-market trading after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $24 to $22.
- Otter Tail Corporation OTTR fell 8.4% to $71.87 in pre-market trading.
- Super Micro Computer, Inc. SMCI dipped 6.1% to $38.01 in pre-market trading. This decline occurred despite reassurances from CEO Charles Liang that the company’s stock would not be delisted from Nasdaq.
- The Hershey Company HSY fell 5.1% to $177.50 in pre-market trading.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.